39 medicines added to list of essentials, prices to come down

NEW DELHI: In a move that may bring down prices of some widely used essential drugs, the government has revised the National List of Essential Medicines, adding 39 new ones under the list for proposed price cap, a source said. Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

The government has also deleted 16 drugs from the existing list and the final NLEM 2021 now contains 399 essential medicines, up from 376 drugs that are currently under direct price control.

The revised list, prepared by an expert committee under the Indian Council of Medical Research, was submitted to health minister Mansukh Mandaviya on Thursday. Once the list is notified by the health ministry, it will be evaluated by the Standing Committee on Affordable Medicines and Health Products (SCAMHP) to assess which of the medicines require price capping.

The final price capping will be done by the National Pharmaceutical Pricing Authority based on the recommendations of the SCAMHP, headed by Niti Aayog member-health Dr V K Paul.

Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

  • Related Posts

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Hyderabad: The collaborative landscape of international pharmaceutical oversight reached a new milestone on May 5, 2026, as the Drugs Control Administration (DCA) of Telangana hosted the Second Regulatory Forum with…

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Spiritualism n Compassion being core of his Nature, Poor Patients may Hope for Best New Delhi: ‘Nishant’ literally meaning daybreak, Bihar may well hope to see a new Dawn of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr